Tumor Ablation Market Size

Tumor Ablation Market Size Grow at 12.9% CAGR, Will Reach USD 2.0 Bn by 2027:Nova one advisor

SHARE THIS ARTICLE

According to Nova one Advisor, the Global Tumor Ablation Market size was valued at USD 650 Million in 2020 and is projected to reach USD 2.0 Billion by 2027, growing at a CAGR of 12.9% from 2021 to 2027.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.novaoneadvisor.com/report/sample/5828

Report Coverage

Report Scope Details
Market Size USD 2.0 Billion by 2027
Growth Rate CAR 12.9% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Largest Market North America
Fastest Growing Market Asia Pacific
Segments  Covered Product, synthesis, drug, application, workflow and Region
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Companies Mentioned Galil Medical Inc.; Misonix Inc.; HealthTronics; Mermaid Medical; Theraclion; Chongqing Haifu Medical Technology Co., Ltd.; HS Hospital Service S.P.A; EDAP TMS S.A.

Growth Factors:

The market Tumor ablation refers to a minimally invasive (MI) technique that is conducted to treat tumors of the kidney, liver, bones and lungs. The ablation system consists of a generator and a needlelike device that delivers the heat directly to the target cells to cause acute cellular necrosis. The procedure destroys benign tumors by inserting a probe and heating it to 100-degree Celsius under Precise Computer Tomography, without extracting them from the body. It can be conducted through Microwave Ablation, Radiofrequency Ablation, Cryoablation, etc. It provides increased accuracy and covers a larger treatment area, along with minimal pain and risk to the patient upon repeated administrations.
The increasing prevalence of cancer is one of the key factors driving the growth of the market. Furthermore, owing to benefits such as the lesser amount of trauma, speedy recovery, reduced complications and shorter hospital stay, MI procedures are gaining widespread preference, which, in turn, is driving the market growth. Also, various technological advancements such as the introduction of thermal and laser ablation, irreversible electroporation and High-Intensity Focused Ultrasound (HIFU) have enhanced the acceptance of tumor ablation procedures. Moreover, the implementation of favorable government policies for cancer awareness and treatment methods is also creating a positive outlook for the market

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Tumor Ablation market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the Tumor Ablation Market include:  Galil Medical Inc.; Misonix Inc.; HealthTronics; Mermaid Medical; Theraclion; Chongqing Haifu Medical Technology Co., Ltd.; HS Hospital Service S.P.A; EDAP TMS S.A.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

  • By Technology
    • Radiofrequency ablation
    • Microwave ablation
    • Cryoablation
    • Irreversible electroporation ablation
    • Other ablation technologies
  • By Treatment
    • Surgical ablation
      • Kidney Cancer
      • Liver cancer
      • Breast cancer
      • Lung cancer
      • Prostate cancer
      • Other cancer
    • Laparoscopic ablation
      • Kidney Cancer
      • Liver cancer
      • Breast cancer
      • Lung cancer
      • Prostate cancer
      • Other cancer
    • Percutaneous ablation
      • Kidney Cancer
      • Liver cancer
      • Breast cancer
      • Lung cancer
      • Prostate cancer
      • Other cancer
  • By Application
    • Kidney Cancer
    • Liver cancer
    • Breast cancer
    • Lung cancer
    • Prostate cancer
    • Other cancer

Regional Segmentation:

– North America Region (U.S., Canada, Mexico)

– Europe Region (Germany, UK, France, Russia, Italy, Rest of Europe)

– Asia-Pacific Region (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

– South America Region (Brazil, Argentina, Columbia, Rest of South America)

– The Middle East & Africa Region (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Get Full Access of This Research Report@ https://www.novaoneadvisor.com/report/checkout/5828

Growing Government and NGO Initiative to Boost Growth of Global Tumor Ablation Market

The global tumor ablation market is likely to register significant growth due to growing awareness among the consumers regarding the new line therapy for the treatment of cancer. Increasing public awareness about the cancer and growing supportive program by the NGO’s and government to supplement growth of the global tumor ablation market in the coming years. In addition, government is actively participating in several research related product to supplement growth of this market in the near future. Moreover, growing acceptance of several technologies is propagating growth of this market in coming years.

Increase in elderly population is boosting demand for minimally invasive surgeries as these technologies helps in reducing the distress with quick recovery. This further fuels the demand for the minimal invasive process such as radiofrequency ablation associated to invasive processes. Furthermore, increase in disposable income in developing and developed economies helping the consumer to prefer progressive therapies over the conventional one. This is one of the key trend supporting growth of the global tumor ablation market in the coming years.

Regional analysis:

North America dominated the tumor ablation market and accounted for the largest revenue share of 35.2% in 2020. Major factors contributing to the growth of this region include government support for quality healthcare, high purchasing power parity, availability of reimbursements, and increasing prevalence of cancer. For instance, in the U.S., the Patient Protection and Affordable Care Act (PPACA) promotes the quality and affordability of health care through health coverage policies, which reduces the cost of healthcare for individuals and the government. In addition, the precision medicine initiative in formulating tailored strategies on unique characteristics of diseases. Hence, such government initiatives are anticipated to improve the overall healthcare system, thus boosting the market growth.

Europe followed North America in terms of revenue share in 2020. A greater extent of public funding in Europe’s healthcare system has contributed to this growth. Moreover, the growing geriatric population coupled with government support to control cancer is estimated to boost the market growth in this region. For instance, the European Cancer Observatory aims to create awareness about cancer, early diagnostic techniques, and advanced, minimally invasive therapeutic options.

In Asia Pacific, the market is expected to register the fastest growth rate during the forecast period. Expanding patient population and a growing presence of major healthcare providers in rapidly developing economies such as India and China open growth opportunities. In addition, with government assistance, healthcare utilization in the Asia Pacific is improving. For instance, the Indian government provides financial assistance for poor patients suffering from cancer under the Health Minister Cancer Patient Fund (HMCPF) scheme.  This is anticipated to fuel the demand for tumor ablation devices in this region over the forecast period.

Despite unprecedented implications of the COVID-19 outbreak, the market will gain impetus amidst soaring investment towards sophistication of the healthcare sector. The market survey offers compelling insights into key factors enabling growth through the assessment period. It underscores hidden opportunities across diverse segments. Besides uncovering hidden opportunities, the report presents exclusive insights into challenges posing threat to growth. Alongside this, it offers recommendations to navigate through unforeseen hindrances in the future, while keeping the business afloat.

Scope of the Study

This Tumor Ablation market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This research report offers scenario and forecast (revenue/volume), and categorizes market by players, type, application, and region. This report also studies global market prominence, competitive landscape, market share, growth rate market dynamics such as drivers, restraints and opportunities, and distributors and sales channel.

This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers competitive scenario which comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

Final Report will add the analysis of the impact of COVID-19 on this industry.

Important years considered for this report:

Historical Years: 2017-2019

Base Year: 2020

Forecast Period: 2021-2027

Key Points Covered in Tumor Ablation Market Survey

  • Demand will remain high in the U.S., backed by favourable reimbursement policies and presence of some of the leading market players.
  • Europe will continue showcasing high demand. Sales will remain high, especially in the U.K., Germany, France, and other countries.
  • China and India will exhibit high demand for Tumor Ablation, backed by expanding healthcare sector.
  • Focus on research and development will increase in Brazil, creating opportunities for the expansion of the Tumor Ablation market.
  • Hospitals are expected to showcase higher demand for Tumor Ablation on account of greater access to advanced technologies and higher footfall of patients.
  • Driven by the presence of some of the leading pharmaceutical producers, demand in the Japan Tumor Ablation market will continue increasing at a high pace.

Some of the key highlights covered in the report include:

  • Tumor Ablation Market Demand-Supply Analysis -The report covers detailed insights into demand and supply forces prevailing in the global Tumor Ablation market. It examines trends and factors influencing demand for Tumor Ablation globally and gauges the impact of the same on the production.
  • Tumor Ablation Pricing Analysis – The report presents exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.
  • Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.
  • Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for Tumor Ablation across the world.
  • Competitive Analysis – Some of the leading market players are profiled in the report on Tumor Ablation. The report offers estimation of share individually helps by the market players and determines the impact of some of their popular strategies.
  • COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.
  • Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global Tumor Ablation market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for Tumor Ablation are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2027 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Table Of Content:

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Tumor Ablation Market, By Technology

7.1.  Tumor Ablation Market, By Technology, 2021-2027

7.1.1.     Radiofrequency ablation

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Microwave ablation

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Cryoablation

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Irreversible electroporation ablation

7.1.4.1.          Market Revenue and Forecast (2016-2027)

7.1.5.     Other ablation technologies

7.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Tumor Ablation Market, By Treatment

8.1.  Tumor Ablation Market, By Treatment, 2021-2027

8.1.1.     Surgical ablation

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Laparoscopic ablation

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Percutaneous ablation

8.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Tumor Ablation Market, By Application

9.1.  Tumor Ablation Market, By Application, 2021-2027

9.1.1.     Kidney Cancer

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Liver cancer

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Breast cancer

9.1.3.1.          Market Revenue and Forecast (2016-2027)

9.1.4.     Lung cancer

9.1.4.1.          Market Revenue and Forecast (2016-2027)

9.1.5.     Prostate cancer

9.1.5.1.          Market Revenue and Forecast (2016-2027)

9.1.6.     Other cancer

9.1.6.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Tumor Ablation  Market, Regional Estimates and Trend Forecast

10.1.          North America

10.1.1.  Market Revenue and Forecast, By Technology (2016-2027)

10.1.2.  Market Revenue and Forecast, By Treatment (2016-2027)

10.1.3.  Market Revenue and Forecast, By Application (2016-2027)

10.1.4.  U.S.

10.1.4.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.1.4.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.1.4.3.       Market Revenue and Forecast, By Application (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.1.5.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.1.5.3.       Market Revenue and Forecast, By Application (2016-2027)

10.2.          Europe

10.2.1.  Market Revenue and Forecast, By Technology (2016-2027)

10.2.2.  Market Revenue and Forecast, By Treatment (2016-2027)

10.2.3.  Market Revenue and Forecast, By Application (2016-2027)

10.2.4.  UK

10.2.4.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.2.4.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.2.4.3.       Market Revenue and Forecast, By Application (2016-2027)

10.2.5.  Germany

10.2.5.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.2.5.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.2.5.3.       Market Revenue and Forecast, By Application (2016-2027)

10.2.6.  France

10.2.6.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.2.6.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.2.6.3.       Market Revenue and Forecast, By Application (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.2.7.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.2.7.3.       Market Revenue and Forecast, By Application (2016-2027)

10.3.          APAC

10.3.1.  Market Revenue and Forecast, By Technology (2016-2027)

10.3.2.  Market Revenue and Forecast, By Treatment (2016-2027)

10.3.3.  Market Revenue and Forecast, By Application (2016-2027)

10.3.4.  India

10.3.4.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.3.4.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.3.4.3.       Market Revenue and Forecast, By Application (2016-2027)

10.3.5.  China

10.3.5.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.3.5.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.3.5.3.       Market Revenue and Forecast, By Application (2016-2027)

10.3.6.  Japan

10.3.6.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.3.6.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.3.6.3.       Market Revenue and Forecast, By Application (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.3.7.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.3.7.3.       Market Revenue and Forecast, By Application (2016-2027)

10.4.          MEA

10.4.1.  Market Revenue and Forecast, By Technology (2016-2027)

10.4.2.  Market Revenue and Forecast, By Treatment (2016-2027)

10.4.3.  Market Revenue and Forecast, By Application (2016-2027)

10.4.4.  GCC

10.4.4.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.4.4.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.4.4.3.       Market Revenue and Forecast, By Application (2016-2027)

10.4.5.  North Africa

10.4.5.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.4.5.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.4.5.3.       Market Revenue and Forecast, By Application (2016-2027)

10.4.6.  South Africa

10.4.6.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.4.6.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.4.6.3.       Market Revenue and Forecast, By Application (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.4.7.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.4.7.3.       Market Revenue and Forecast, By Application (2016-2027)

10.5.          Latin America

10.5.1.  Market Revenue and Forecast, By Technology (2016-2027)

10.5.2.  Market Revenue and Forecast, By Treatment (2016-2027)

10.5.3.  Market Revenue and Forecast, By Application (2016-2027)

10.5.4.  Brazil

10.5.4.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.5.4.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.5.4.3.       Market Revenue and Forecast, By Application (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.       Market Revenue and Forecast, By Technology (2016-2027)

10.5.5.2.       Market Revenue and Forecast, By Treatment (2016-2027)

10.5.5.3.       Market Revenue and Forecast, By Application (2016-2027)

Chapter 11.   Company Profiles

11.1.                 Galil Medical Inc.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.                 Misonix Inc.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.                 HealthTronics

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.                 Mermaid Medical

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.                 Theraclion

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.                 Chongqing Haifu Medical Technology Co., Ltd.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.                 HS Hospital Service S.P.A

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.                 EDAP TMS S.A

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

Chapter 12.   Research Methodology

12.1.                 Primary Research

12.2.                 Secondary Research

12.3.                 Assumptions

Chapter 13.   Appendix

13.1.                 About Us

13.2.                 Glossary of Terms

Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/5828

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: – sales@novaoneadvisor.com

Web – https://www.novaoneadvisor.com/

James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →

Leave a Reply

Your email address will not be published.